- The Green Organic Dutchman produces high-quality, organic cannabis for the medicinal and recreational adult use markets from purpose-built, state-of-the-art facilities
- The company has confirmed higher demand for premium organic cannabis
- TGOD has also announced positive results from its pharmacokinetic study of innovative cannabinoid technology
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is an international, premium organic cannabis company based in Mississauga, Ontario. The company produces high-quality, organic medical and recreational adult use cannabis using organic craft growing principles. TGOD plans on commercializing organic cannabinoid dissolvables in Canada beginning in December 2019 under the TGOD-Infusers line of premium cannabis products, and results from a recent study have given support to that move. Additionally, TGOD was able to report strong demand for its premium organic cannabis following its Ontario launch and fast-tracked shipments.
Following its Ontario launch and fast-tracked shipments, TGOD reported that there is a strong demand for its premium organic cannabis (http://cnw.fm/1kZf4). After the August launch, initial demand surpassed expectations. The company’s high-THC (tetrahydrocannabinol) signature strain, Unite Organic, performed well both online and at dispensaries, resulting in a second order from the Ontario Cannabis Store – earlier than initially anticipated. The strong launch marks TGOD’s successful entrance into the Canadian recreational market.
While cannabis companies abound, TGOD continues to impress with its organic emphasis and the overall quality of its products. TGOD’s cannabis is grown in its proprietary living soil, in accordance with all-natural principles. Moreover, its growing process is certified organic by Pro-Cert and ECOCERT, two top organic certification bodies. Of note is the fact that, according to a 2019 study conducted by Hill & Knowlton, more than 50 percent of recreational consumers intending to purchase cannabis stated that it is important that their cannabis be organic, and over 60 percent of medical patients prefer organic cannabis. As one of the few certified-organic companies in Canada, these numbers give TGOD an edge in the market.
While TGOD’s premium cannabis products are thriving, the company also plans on introducing organic CBD-dissolvables to the market. In line with that goal, TGOD and Caliper Foods recently reported positive results from a pharmacokinetic study of proprietary, water-soluble cannabinoid technology (http://cnw.fm/Axz5O). The two companies revealed the results of a preliminary human pharmacokinetic (PK) study of Caliper CBD, Caliper Foods’ proprietary tasteless, odorless, water-soluble powder, which can be added to almost any food or beverage. Caliper Foods is a best-in-class provider of water-soluble cannabinoid products.
In the study, half of the participants were administered 30 milligrams of Caliper Foods’ water-soluble CBD powder in eight ounces of water; the other half received 30 milligrams of CBD dispersed in MCT oil. Early data shows that the group that received Caliper CBD demonstrated speedier onset within 15 minutes, with higher concentrations attained at 15 minutes versus the maximum concentration attained at 45 minutes with the CBD-in-oil formulation, and a 4.5-fold higher observed total bioavailability.
“We are thrilled with the results of this preliminary PK study, which demonstrate the consistency and precision of Caliper Foods’ proven proprietary technology, which is already available in Colorado and which TGOD will commercialize in Canada,” TGOD Chief Science Officer Dr. Rav Kumar stated in a news release (http://cnw.fm/d1XCT). “Based on this early data, Caliper CBD provides a higher and faster absorption level when compared with CBD-infused oil, which opens a number of possibilities for both the medical and adult-use markets.”
With its proven management team and state-of-the-art facilities, TGOD continues to focus on providing a slate of premium consumer-preferred products. The company offers investors potential return on investment as it looks to grow via strategic international opportunities. TGOD’s hybrid facilities represent important advantages over indoor and outdoor greenhouses and set the stage for lower capex and greater profits.
TGOD’s operational emphasis is on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company’s strategy is to grow organically and at low costs, resulting in a product that demands a premium in the marketplace, thereby increasing the company’s margins.
For more information, visit the company’s website at www.TGOD.ca
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGODF
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor